☆ 4.6 Editorial Material

Do CCR5 antagonists improve the overall survival of patients with AIDS-related progressive multifocal leucoencephalopathy?

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Get Full Text
Add to Collection

Journal

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 89, Issue 10, Pages 1125-1126

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp-2017-317203

Keywords

-

Categories

Clinical Neurology Psychiatry Surgery

Funding

  1. Abbvie
  2. Pfizer
  3. ViiV Healthcare France
  4. Eumedica France
  5. Allergan
  6. Thea
  7. Alcon
  8. BMS
  9. Gilead
  10. Abbvie Viiv Healthcare
  11. GSK
  12. Janssen
  13. MSD
  14. Nephrotek
  15. Merck-Sharp-Dome
  16. Bristol-Myers-Squibb
  17. Viiv Healthcare
  18. Gilead Sciences
  19. Janssen Pharmaceuticals
  20. Genmark
  21. Biogen Idec
  22. Novartis
  23. Merck-Serono
  24. Teva

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.